This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The Drug Enforcement Administration (DEA) got a slap on the wrist from a federal watchdog agency over its management of a multi-million dollar marijuana eradication program. But due to inadequate record keeping, the DEA doesn’t really know if that money is serving its purpose. each year to help them get rid of illegal cannabis grows.
This article reviews the insights gained to date from the government’s disclosures, or lack thereof, to the Initiative’s public records requests. Drug Enforcement Agency (“DEA”). Discover the Indigenous Reciprocity Initiative of the Americas. Customs Border Patrol (“CBP”) and U.S. Department of the Navy , 562 U.S. 562 [2011]).
Drug Enforcement Administration (DEA) this week challenging the government’s Schedule I classification of psilocybin, the main psychoactive component of psychedelic mushrooms. Read full article. Seattle Doctor Files DEA Petition To Reschedule Psilocybin For Medical Use. Marijuana Moment.
The Drug Enforcement Administration made a milestone announcement earlier this month with the news that the DEA will begin granting marijuana cultivation licenses to various third-party applicants, significantly expanding medical and scientific cannabis research in the United States.
The DEA published a new document in the Federal Register on September 2 requesting an increase in production for certain Schedule I and Schedule II substances so that it can initiate more research studies. . DEA firmly believes in supporting regulated research of schedule I controlled substances. View original article.
Drug Enforcement Administration (DEA) quietly made an announcement that’s expected to have a profound and long-lasting impact on cannabis research and development in the United States. Leafly’s Ben Adlin documented the shockingly poor quality in this 2017 article : Smoking 25% THC, studying 8% THC. DEA finally relents.
Well, the DEA just released its 2020 National Drug Threat Assessment, and the report is full of stats on the United States’ most popular illegal addictions, new trends in intoxicants, and foreign trade — a.k.a. The US sourced 92 percent of its heroin from Mexico in 2019, according to product analyzed by a DEA tracing program.
However, the document also states “the cut shall be made just underneath a flowering material”. Another potential headache for farmers is that analytical laboratories must be registered with the DEA in order to perform compliance testing. New Sampling Guidelines. This guidance is in line with the common international standards.
The DEA’s announcement signals the “beginning of the end” of federal marijuana prohibition, as the policy change allows federal agencies to evaluate and assess the medical use and abuse potential of marijuana with (limited) political interference. BY EMILY BURNS, GREEN LIGHT LAW GROUP —.
When asked if that’s because of language from the Drug Enforcement Administration (DEA) that states that tetrahydrocannabinols are illegal when synthetically produced from cannabis, he said, “Right, that’s true. Delta-8 isn’t mentioned by name in the 2018 Farm Bill, the DEA’s IFR or the Controlled Substances Act.
When asked if that’s because of language from the Drug Enforcement Administration (DEA) that states that tetrahydrocannabinols are illegal when synthetically produced from cannabis, he said, “Right, that’s true. Delta-8 isn’t mentioned by name in the 2018 Farm Bill, the DEA’s IFR or the Controlled Substances Act.
Epidiolex, an FDA-approved medication containing CBD (cannabidiol), has been listed as Schedule 5 by the DEA since June 25th, 2019. A cannabis prescription is a legal document that allows you to obtain medical marijuana. A cannabis prescription is a prescription written by a doctor to be used as medical marijuana.
Officials say that the 10-day bust decommissioned 205 illegal grow sites in the desert, but that some 500 were documented when the air was surveilled by air. A DEA report released in March said that the agency is seizing about 80 percent less cannabis at the US-Mexican border as compared to 2013. View original article.
At the time of this article’s publishing, thirty states and the District of Columbia have enacted legislation permitting use of medical cannabis. Doctors may not prescribe cannabis products to patients because marijuana is currently listed as an example of a Schedule I drug according to the DEA.
When asked if that’s because of language from the Drug Enforcement Administration (DEA) that states that tetrahydrocannabinols are illegal when synthetically produced from cannabis, he said, “Right, that’s true. Delta-8 isn’t mentioned by name in the 2018 Farm Bill, the DEA’s IFR or the Controlled Substances Act.
We happened upon an article about a New York conference that both piqued our curiosity and reminded us of another conference which was held in Upstate New York a bit over sixty years ago. All opinions and assertions in this article are those of the author and not of Cannabis Law Report.
In this article, when we use the term “THC” without a modifier, we are referring to delta-9 THC.) . The federal Drug Enforcement Administration (DEA) has, in a proposed rule, indirectly classified delta-8 THC as a Schedule I controlled substance, which would make it federally illegal. View Leafly Staff’s articles.
A state investigation can involve document requests, employee interviews, product testing, and, in the event of a negative finding, lead to a possible suspension of product shipments or license revocation. Guidance in that initial stage should therefore be well documented and provided to regulators in the event of a subsequent investigation.
A state investigation can involve document requests, employee interviews, product testing, and, in the event of a negative finding, lead to a possible suspension of product shipments or license revocation. Guidance in that initial stage should therefore be well documented and provided to regulators in the event of a subsequent investigation.
A state investigation can involve document requests, employee interviews, product testing, and, in the event of a negative finding, lead to a possible suspension of product shipments or license revocation. Guidance in that initial stage should therefore be well documented and provided to regulators in the event of a subsequent investigation.
A state investigation can involve document requests, employee interviews, product testing, and, in the event of a negative finding, lead to a possible suspension of product shipments or license revocation. Guidance in that initial stage should therefore be well documented and provided to regulators in the event of a subsequent investigation.
For example, the Arizona Department of Agriculture (ADOA) has a document that sets forth the requirements that must be met for a registered pesticide product to be used on hemp. pursuant to Drug Enforcement Agency (DEA) or state-level programs). Water Issues.
8-THC’s status under the Controlled Substances Act, the Drug Enforcement Agency (DEA) stated that ?8-THC 8-THC product is synthetic and not extracted from a cannabis plant based on the Forbes article stating that cannabis plants contain too little ?8-THC Conversely, “cannabinoids extracted from the cannabis plant that have a ?
In fact, the United States Drug Enforcement Agency (DEA) issued a private letter ruling in September 2021 making clear that so long as Delta-8 has been extracted from a hemp plant (rather than a marijuana plant that contains.3% Get corporate documents in order. What does this mean for New York cannabis entrepreneurs?
A state investigation can involve document requests, employee interviews, product testing, and, in the event of a negative finding, lead to a possible suspension of product shipments or license revocation. Guidance in that initial stage should therefore be well documented and provided to regulators in the event of a subsequent investigation.
Earl Blumenauer (D-OR) writes in the eight-page document addressed to House Democratic Leadership : “We have an opportunity to correct course if Democrats win big in November. Cannabis is not a “gateway” drug, according to the ASA and the DEA’s own statements cited in the August 2016 U.S. Federal Register. .
A timeline of Florida’s battle for solid ground has been outlined in depth throughout my previous articles. Nationally, University of California, Davis “ Partners With DEA-Approved Company to Conduct Cannabis Research – Researchers Will Seek to Better Understand the Science of Cannabis, ” as outlined by Amy Quinton. .
And now the DEA just recently poked their head into that too, so I think there’s a lot of question marks for both cultivators and processors with respect to hemp. It’s just a nice little entry-level document to provide basic education for people who are curious about the cannabis extraction industry. View original article.
Those of you beginning to pick up regulated cannabis clients might find this article a useful and interesting read. This article focuses on analyzing the guidance on this topic from the state boards of accountancy and Tax Court cases. As of October 21, 33 states and the District of Columbia have allowed the use of medical marijuana.
This creates a somewhat confusing landscape for mothers who might benefit from cannabis-based therapies, but are also concerned for the safety of their child and the very real possibility of institutional intervention when marijuana use during pregnancy is documented. WHO USES CANNABIS DURING PREGNANCY AND WHY?
Leafly recently documented the factors involved in the cannabis industry’s diversity problem, and ways to address it, in the report Seeds of Change: Strategies to create an equitable cannabis industry. Take the DEA out of the cannabis law enforcement business. View Bruce Barcott’s articles. View original article.
Any other documentation that provides proof of residential address as determined by department rule. A progress note or physician-signed acknowledgment is ideal documentation (as long as it includes your doctor’s name, signature, and your diagnosed condition). More details regarding residency requirements are provided below.
A Los Angeles Times article September 11 th that was headlined “Nearly” stated, ‘The audit [1] , conducted by the United Cannabis Business Association. [2] The September 11 th article continues, “ This year, an industry-backed financial audit projected that roughly $8.7 The Articles of Incorporation state is an IRC Sec.
I have an article in there called “Bicycle Day.” I’m starting to get involved in this space and this article was the first step in introducing the ABA to it. The Drug Enforcement Administration (DEA) said in a letter that marijuana seed that has a delta-9-THC concentration of not more than 0.3% cannabis-spring2022newsletter.
Some companies fake or manipulate their COA results , as Molly Longman details in a Refinery29 article, in which Hempire Direct is found to have shown (at least) two fake COAs on their website, with a lab director from Kaycha Labs Colorado explaining: “They took our COA and edited it, thereby falsifying it.
At the time that this article was written, there has been at least one death connected to this scourge. Three months ago, Kenneth Morrow’s June 18, 2019 article What’s in Your Vape Cartridge. This health problem is a direct result of federal cannabis prohibition. The record-high support comes in spite of the federal illegality.”
This filing must contain among other things extensive information and certifications about the offeror of the securities, the investment project manager, and all of the offering and investment documentation provided to investors. As Kate Robertson pointed out in her article, this appears to be what Bright Green has done.
Here’s the introduction to their article. Erinn Baldeschwiler, a Washington state mother of two in the final months of metastatic breast cancer, has been denied access to psilocybin by the DEA, even though she is suffering with the knowledge she won’t live long enough to raise her children.
Some of those dollars for ONCDP would be transferred to the Drug Enforcement Administration (DEA) to “improve coordination of drug enforcement efforts among Federal, State, and local law enforcement agencies in the U.S.” through the High Intensity Drug Trafficking Area program, the document states. View the full article here.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content